transplant model
Recently Published Documents


TOTAL DOCUMENTS

485
(FIVE YEARS 56)

H-INDEX

36
(FIVE YEARS 4)

2021 ◽  
Vol 233 (5) ◽  
pp. S271
Author(s):  
John T. Langford ◽  
Luis H. Gonzalez ◽  
Ryosuke T. Taniguchi ◽  
Anand H. Brahmandam ◽  
Weichang T. Zhang ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Louisa Steines ◽  
Helen Poth ◽  
Antonia Schuster ◽  
Kerstin Amann ◽  
Bernhard Banas ◽  
...  

We aimed to investigate the mechanisms of humoral immune activation in ABMR using a MHC-mismatched rat kidney transplant model. We applied low dose cyclosporine A (loCNI) to allow donor-specific antibody (DSA) formation and rejection and high dose cyclosporine A (hiCNI) for non-rejection. DSA and leukocyte subsets were measured by flow cytometry. Germinal centers (GC), T follicular helper cells (Tfh), plasma cells and interleukin-21 (IL-21) expression were analyzed by immunofluorescence microscopy. Expression of important costimulatory molecules and cytokines was measured by qRT-PCR. Allograft rejection was evaluated by a nephropathologist. We found that DSA formation correlated with GC frequency and expansion, and that GC size was linked to the number of activated Tfh. In hiCNI, GC and activated Tfh were virtually absent, resulting in fewer plasma cells and no DSA or ABMR. Expression of B cell activating T cell cytokine IL-21 was substantially inhibited in hiCNI, but not in loCNI. In addition, hiCNI showed lower expression of ICOS ligand and IL-6, which stimulate Tfh differentiation and maintenance. Overall, Tfh:B cell crosstalk was controlled only by hiCNI treatment, preventing the development of DSA and ABMR. Additional strategies targeting Tfh:B cell interactions are needed for preventing alloantibody formation and ABMR.


Cancers ◽  
2021 ◽  
Vol 13 (11) ◽  
pp. 2619
Author(s):  
Maria Schubert ◽  
Franz Josef Gassner ◽  
Michael Huemer ◽  
Jan Philip Höpner ◽  
Ekaterina Akimova ◽  
...  

Adaptive somatic mutations conferring treatment resistance and accelerated disease progression is still a major problem in cancer therapy. Additionally in CLL, patients receiving novel, efficient drugs frequently become treatment refractory and eventually relapse. Activation-induced deaminase (AID) is a cytosine deaminase that catalyzes somatic hypermutation of genomic DNA at the immunoglobulin locus in activated B cells. As considerable off-target mutations by AID have been discerned in chronic lymphocytic leukemia, it is essential to investigate to which extent these mutations contribute to disease progression to estimate whether AID inhibition could counteract drug resistance mechanisms. In this study, we examined the TCL1 mouse model for CLL on an AID pro- and deficient background by comparing disease development and mutational landscapes. We provide evidence that AID contributes to the acquisition of somatic cancer-specific mutations also in the TCL1 model and accelerates CLL development particularly in the transplant setting. We conclude that AID is directly determining the fitness of the CLL clone, which prompts further studies to assess the effect of AID inhibition on the occurrence of drug resistance.


2021 ◽  
pp. 101415
Author(s):  
Isabella Hanka ◽  
Thomas Stamminger ◽  
Martina Ramsperger-Gleixner ◽  
V. Annika Kuckhahn ◽  
Regina Müller ◽  
...  

2021 ◽  
pp. 110039
Author(s):  
Swati Jain ◽  
Robert Plenter ◽  
Rahkola Jeremy ◽  
Trevor Nydam ◽  
Ronald G. Gill ◽  
...  

2021 ◽  
Author(s):  
Darragh P. O’Brien ◽  
Adam M. Thorne ◽  
Honglei Huang ◽  
Xuan Yao ◽  
Peter Søndergaard Thyrrestrup ◽  
...  

ABSTRACTBackgroundRemote Ischemic Conditioning (RIC) has been proposed as a therapeutic intervention to circumvent the Ischemia/reperfusion injury (IRI) that is inherent to organ transplantation. Using a porcine kidney transplant model, we aimed to decipher the subclinical molecular effects of a RIC regime, compared to non-RIC controls.MethodsKidney pairs (n = 8+8) were extracted from brain dead donor pigs and transplanted in juvenile recipient pigs following a period of cold ischemia. One of the two kidney recipients in each pair was subjected to RIC prior to kidney graft reperfusion, while the other served as non-RIC control. We designed an advanced integrative Omics strategy combining transcriptomics, proteomics, and phosphoproteomics to deduce molecular signatures in kidney tissue that could be attributed to RIC.ResultsIn kidney grafts taken out 10 h after transplantation we detected minimal molecular perturbations following RIC compared to non-RIC at the transcriptome level, but more pronounced effects at the proteome level. In particular, we noted that RIC resulted in suppression of tissue inflammatory profiles. Furthermore, an accumulation of muscle extracellular matrix assembly proteins in kidney tissues was detected at the protein level, which may be in response to muscle tissue damage and/or fibrosis.ConclusionsOur data identifies subtle molecular phenotypes in porcine kidneys following RIC and this knowledge could potentially aid optimisation of remote ischaemia protocols in renal transplantation.


2021 ◽  
Vol 40 (4) ◽  
pp. S228
Author(s):  
L.R. Gokanapudy Hahn ◽  
S. Yang ◽  
A. Bredemeyer ◽  
H. Dun ◽  
I. Lokshina ◽  
...  

2021 ◽  
Vol 40 (4) ◽  
pp. S54
Author(s):  
M. Kawashima ◽  
G. Teskey ◽  
B. Joe ◽  
H. Buhari ◽  
J. Oliver ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document